ISRCTN16838474
Completed
未知
Post-marketing observational study to follow-up patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis who are treated with ExemptiaTM (Adalimumab).
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Juvenile Idiopathic Arthritis
- Sponsor
- Cadila Healthcare Ltd.
- Enrollment
- 149
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
2019 results in patients with rheumatoid arthritis in: https://www.ncbi.nlm.nih.gov/pubmed/31254222 (added 09/07/2019) 2019 results in patients with ankylosing spondylitis in: https://www.ncbi.nlm.nih.gov/pubmed/31777828 (added 02/12/2019)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. \=2 years up to 75 years old
- •2\. Diagnosis as per current guidelines published by ACR/EULAR/CASPAR/ILAR guidelines of:
- •2\.1\. Rheumatoid Arthritis
- •2\.2\. Ankylosing Spondylitis
- •2\.3\. Psoriatic arthritis
- •2\.4\. Juvenile Idiopathic Arthritis (JIA)
- •3\. Treatment with ExemptiaTM (Adalimumab)
- •4\. Subjects and/or their parent/ legal guardian were willing to be contacted in the future by study staff.
Exclusion Criteria
- •1\. Subjects receiving Adalimumab other than ExemptiaTM (Adalimumab)
- •2\. Any contraindication for ExemptiaTM (Adalimumab) or concomitant drug like CNS and myeloid disorders according to Prescribing Information
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )Rheumatoid ArthritisPsoriatic ArthritisAnkylosing SpondylitisNCT01078558AbbVie (prior sponsor, Abbott)5,940
Completed
Not Applicable
An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid ArthritisRheumatoid Arthritis (RA)NCT04267536AbbVie534
Completed
Not Applicable
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeRheumatoid ArthritisAnkylosing SpondylitisPsoriatic ArthritisCrohn´s DiseaseUlcerative ColitisPlaque PsoriasisNCT01768858AbbVie96
Completed
Not Applicable
A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)Rheumatoid ArthritisNCT00705289Merck Sharp & Dohme LLC728
Completed
Not Applicable
A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic ArthritisRheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsA)NCT04541810AbbVie2,369